Registered entities
Actuate Therapeutics, Inc.
Reg. No. 32056578290United States
Innovation
10 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 373 times.
| Year | Filings |
|---|---|
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 6 |
| 2023 | 4 |
| 2024 | 6 |
| 2025 | 8 |
| 2026 | 2 |
Social engagement
Social engagement: 2K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
6 investors on record; lead investors include Kairos Ventures, Bios Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 67% |
| Angel & family office | 2 | 33% |
Recent activity
26 Jun 2026
Product launch
elraglusib
1 Jun 2026
Event
2026 American Society of Clinical Oncology (ASCO) Annual Meeting
28 May 2026
Event
American Society of Clinical Oncology (ASCO) Annual Meeting